Design and development of advanced integrated ultrasound for hemorrhage diagnostic and targeted drug delivery using nanoparticles for combat casualty care
Active Cooperative Agreement Awarded Last action
- Award ID
- HR0011262E012
- Recipient
-
Massachusetts Institute Of Technology UEI E2NYLCDML6V1
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $1,362,266
Award facts
- Assistance listing
- 12.910 Research and Technology Development
- Completion date 77% complete
- Place of performance
- Cambridge, MA 02139, USA
Award details come from USAspending.gov.
About this award
The Defense Advanced Research Projects Agency awarded Massachusetts Institute of Technology a $1.362 million cooperative agreement on January 21, 2026, under the Research and Technology Development program (CFDA 12.910) to design and develop advanced integrated ultrasound for hemorrhage diagnostic and targeted drug delivery using nanoparticles for combat casualty care. The award is a DARPA Seedling project. Performance will occur in Cambridge, Massachusetts through January 20, 2027. The cooperative agreement structure supports DARPA's mission to advance basic and applied research with potential military or dual-use application through competitive merit-based selection.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $1,021,266 | |
| Original award | $341,000 |
Quick answers
Who received award HR0011262E012?
HR0011262E012 was awarded to Massachusetts Institute Of Technology by Defense Advanced Research Projects Agency (Department of Defense) on January 21, 2026.
How much is award HR0011262E012 worth?
$1,362,266 has been obligated on HR0011262E012.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award